You are here
AdvaMed Urges House Passage of MDUFA Reauthorization Bill
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker regarding the planned vote in the U.S. House on the FDA Reauthorization Act of 2017:
"AdvaMed is pleased the full House will be taking up the FDA Reauthorization Act this week. Passage of this legislation will help patients everywhere as it will bring us one step closer to helping FDA fulfill its crucial mission to ensure the availability of safe and effective medical devices and diagnostics.
"The robust performance goals, process improvements, increased accountability and additional resources built into the new user fee agreement mean that patients will benefit from more timely access to the latest medical innovations and companies will benefit from greater certainty as they plan for the next-generation of advancements.
"We encourage members of the House to vote in favor of this important legislation and urge their Senate colleagues to follow suit as soon as possible."